There are 2934 resources available
How to evaluate drugs in combination: A regulatory perspective
Presenter: Francesco Pignatti
Session: Drugs in combination
Resources:
Slides
Webcast
Establishing cost-effectiveness in combinations
Presenter: Carla Deakin
Session: Drugs in combination
Resources:
Slides
Webcast
And who is going to pay for it all? A payer’s perspective
Presenter: Linda van Saase
Session: Drugs in combination
Resources:
Slides
Webcast
Imaging of gastrointestinal stromal tumours
Presenter: Daniele Regge
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Surgical management
Presenter: William Allum
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Case-based panel discussion
Presenter: Daniele Regge
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Proffered Paper – CNS tumours - Invited Discussant 390O and 391O
Presenter: Paul Clement
Session: Proffered Paper – CNS tumours
Resources:
Slides
Webcast
5130 - OCTOPUS - A Randomised, Multi-centre Phase II Umbrella Trial of Weekly Paclitaxel+/- Novel Agents in Platinum-Resistant Ovarian Cancer: vistusertib
Presenter: Susana Banerjee
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
1638 - Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
Presenter: Fabrice Barlesi
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides
Webcast
4648 - Prognostic role of the EANO ESMO classification of leptomeningeal metastases
Presenter: Emilie Le Rhun
Session: Proffered Paper – CNS tumours
Resources:
Abstract
Slides